“…The participants comprised 1236 children with IgAV-N (48% male, median age 8.0 years), 761 healthy paediatric controls (52% male, median age 7.9 years) and 449 children with IgAV-noN (52% male, median age 7.0 years). The publication dates spanned from 2011-2020 [13,14,17,27] and included both longitudinal [13,17,18,24,28,29] and cross-sectional studies [12,14,15,19,22,23,27]. The majority of the papers were published from China [12, 14, 17, 18, 22-24, 27, 28, 30], and three studies were from Poland [13], France [19] and Mexico [15].…”